Literature DB >> 28125218

Identification of a Ligand-Binding Site on the Staphylococcus aureus DnaG Primase C-Terminal Domain.

Jonathan Catazaro1, Jessica Periago1, Matthew D Shortridge1, Bradley Worley1, Andrew Kirchner1, Robert Powers1, Mark A Griep1.   

Abstract

The interface between the DnaG primase C-terminal domain (CTD) and the N-terminal domain of DnaB helicase is essential for bacterial DNA replication because it allows coordinated priming of DNA synthesis at the replication fork while the DNA is being unwound. Because these two proteins are conserved in all bacteria and distinct from those in eukaryotes, their interface is an attractive antibiotic target. To learn more about this interface, we determined the solution structure and dynamics of the DnaG primase CTD from Staphylococcus aureus, a medically important bacterial species. Comparison with the known primase CTD structures shows there are two biologically relevant conformations, an open conformation that likely binds to DnaB helicase and a closed conformation that does not. The S. aureus primase CTD is in the closed conformation, but nuclear magnetic resonance (NMR) dynamic studies indicate there is considerable movement in the linker between the two subdomains and that N564 is the most dynamic residue within the linker. A high-throughput NMR ligand affinity screen identified potential binding compounds, among which were acycloguanosine and myricetin. Although the affinity for these compounds and adenosine was in the millimolar range, all three bind to a common pocket that is present only on the closed conformation of the CTD. This binding pocket is at the opposite end of helices 6 and 7 from N564, the key hinge residue. The identification of this binding pocket should allow the development of stronger-binding ligands that can prevent formation of the CTD open conformation that binds to DnaB helicase.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28125218      PMCID: PMC6476306          DOI: 10.1021/acs.biochem.6b01273

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  57 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Primus inter pares (first among equals).

Authors:  J L Keck; J M Berger
Journal:  Nat Struct Biol       Date:  2001-01

3.  DnaB helicase stimulates primer synthesis activity on short oligonucleotide templates.

Authors:  S K Johnson; S Bhattacharyya; M A Griep
Journal:  Biochemistry       Date:  2000-02-01       Impact factor: 3.162

4.  Structure of the zinc-binding domain of Bacillus stearothermophilus DNA primase.

Authors:  H Pan; D B Wigley
Journal:  Structure       Date:  2000-03-15       Impact factor: 5.006

5.  A TOPRIM domain in the crystal structure of the catalytic core of Escherichia coli primase confirms a structural link to DNA topoisomerases.

Authors:  M Podobnik; P McInerney; M O'Donnell; J Kuriyan
Journal:  J Mol Biol       Date:  2000-07-07       Impact factor: 5.469

6.  Influence of non-bonded parameters on the quality of NMR structures: a new force field for NMR structure calculation.

Authors:  J P Linge; M Nilges
Journal:  J Biomol NMR       Date:  1999-01       Impact factor: 2.835

Review 7.  DNA primases.

Authors:  D N Frick; C C Richardson
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

8.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

9.  Sources of and solutions to problems in the refinement of protein NMR structures against torsion angle potentials of mean force.

Authors:  J Kuszewski; G M Clore
Journal:  J Magn Reson       Date:  2000-10       Impact factor: 2.229

10.  Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.

Authors:  James J Crute; Christine A Grygon; Karl D Hargrave; Bruno Simoneau; Anne-Marie Faucher; Gordon Bolger; Philip Kibler; Michel Liuzzi; Michael G Cordingley
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

View more
  1 in total

1.  Theoretical Development of DnaG Primase as a Novel Narrow-Spectrum Antibiotic Target.

Authors:  Jessica Periago; Clarissa Mason; Mark A Griep
Journal:  ACS Omega       Date:  2022-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.